Herpud1 deficiency alleviates homocysteine-induced aortic valve calcification

Wenqing Xie1,2, Yue Shan3, Zhuonan Wu4

  • 1Department of Cardiology, Shaoxing People's Hospital, Shaoxing Hospital, Zhejiang University School of Medicine, Shaoxing, 312000, Zhejiang, China.

Insights

Homocysteine (hcy) promotes calcific aortic valve disease (CAVD) by increasing Herpud1 expression via endoplasmic reticulum stress (ERS). Silencing Herpud1 or inhibiting ERS reduces CAVD progression, offering a potential therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Cellular Pathophysiology

Background:

  • Calcific aortic valve disease (CAVD) has high morbidity and mortality with limited treatment options.
  • Homocysteine (hcy) is implicated in CAVD progression.
  • The role of endoplasmic reticulum stress (ERS) and specific proteins in hcy-induced CAVD is not fully understood.

Purpose of the Study:

  • To investigate the role of the hcy-inducible ERS protein Herpud1 in hcy-induced CAVD.
  • To evaluate Herpud1 as a potential therapeutic target for CAVD.

Main Methods:

  • Utilized low-density lipoprotein receptor (LDLR) and Herpud1 double knockout mice fed a high methionine diet (HMD) to study in vivo CAVD.
  • Assessed aortic valve calcification, ERS activation, autophagy, and osteogenic differentiation of aortic valve interstitial cells (AVICs).
  • Investigated Herpud1's role in hcy-related AVIC osteogenic differentiation in vitro by manipulating Herpud1 expression.

Main Results:

  • Herpud1 was highly expressed in calcified human and mouse aortic valves and AVICs.
  • Hcy increased Herpud1 expression via ERS, promoting CAVD; Herpud1 deficiency inhibited hcy-induced CAVD.
  • Herpud1 silencing activated autophagy, inhibiting hcy-induced AVIC osteogenic differentiation; ERS inhibition (4-PBA) reduced aortic valve calcification.

Conclusions:

  • Herpud1 is upregulated in hcy-related CAVD through the ERS pathway.
  • Herpud1 deficiency or inhibition mitigates hcy-induced CAVD progression.
  • Herpud1 silencing or inhibition represents a promising therapeutic strategy for CAVD.
Abstract

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
27
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
25
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
43
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
24
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
31